Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Vericel Corp | Financial_Report.xls |
| EX-21 - EX-21 - Vericel Corp | a11-31698_1ex21.htm |
| EX-31.2 - EX-31.2 - Vericel Corp | a11-31698_1ex31d2.htm |
| EX-32.1 - EX-32.1 - Vericel Corp | a11-31698_1ex32d1.htm |
| 10-K - 10-K - Vericel Corp | a11-31698_110k.htm |
| EX-31.1 - EX-31.1 - Vericel Corp | a11-31698_1ex31d1.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-155739, 333-108989, 333-107579, 333-170581 and 333-174945) and Form S-8 (Nos. 333-163832, 333-140624, 333-121006, 333-115505, 333-81340, 333-51556, 333-38886, 333-140624, 333-25021 and 333-174758) of Aastrom Biosciences, Inc. (a development stage company) of our report dated March 15, 2012 relating to the consolidated financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
|
/s/PricewaterhouseCoopers LLP |
|
Detroit, Michigan |
|
March 15, 2012 |